InfuSystems Holdings Inc INFU
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INFU is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $8.80
- Day Range
- $8.55–8.85
- 52-Week Range
- $7.45–11.44
- Bid/Ask
- $8.57 / $9.44
- Market Cap
- $181.66 Mil
- Volume/Avg
- 44,560 / 45,222
Key Statistics
- Price/Earnings (Normalized)
- 106.21
- Price/Sales
- 1.60
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 1.02%
Company Profile
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 438
- Website
- http://www.infusystem.com
Comparables
Valuation
Metric
|
INFU
|
LUNG
|
OM
|
---|---|---|---|
Price/Earnings (Normalized) | 106.21 | — | — |
Price/Book Value | 3.62 | 2.97 | 0.90 |
Price/Sales | 1.60 | 5.04 | 0.84 |
Price/Cash Flow | 11.86 | — | — |
Price/Earnings
INFU
LUNG
OM
Financial Strength
Metric
|
INFU
|
LUNG
|
OM
|
---|---|---|---|
Quick Ratio | 1.37 | 5.62 | 4.27 |
Current Ratio | 2.08 | 6.50 | 5.26 |
Interest Coverage | 1.80 | −19.37 | −13.39 |
Quick Ratio
INFU
LUNG
OM
Profitability
Metric
|
INFU
|
LUNG
|
OM
|
---|---|---|---|
Return on Assets (Normalized) | 2.71% | −22.61% | −39.03% |
Return on Equity (Normalized) | 5.59% | −31.80% | −72.89% |
Return on Invested Capital (Normalized) | 5.03% | −25.75% | −44.98% |
Return on Assets
INFU
LUNG
OM
Medical Instruments & Supplies Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Hyvwspktsk | Ctbx | $141.8 Bil | |
BDX
| Becton Dickinson & Co | Vhbkcfd | Lgwzlk | $71.2 Bil | |
ALC
| Alcon Inc | Szdydgf | Cdwxj | $41.1 Bil | |
CLPBY
| Coloplast A/S ADR | Whgrchvkv | Zhch | $30.4 Bil | |
RMD
| ResMed Inc | Dwxdqjvy | Bltyz | $28.9 Bil | |
WST
| West Pharmaceutical Services Inc | Bsqgxnprpk | Tvnc | $28.9 Bil | |
BAX
| Baxter International Inc | Jkcbjjmcx | Djvfxw | $21.7 Bil | |
COO
| The Cooper Companies Inc | Czsqjymyj | Qtxdsv | $20.2 Bil | |
HOLX
| Hologic Inc | Lbgryscv | Pjymqm | $18.2 Bil | |
TFX
| Teleflex Inc | Hwph | Ywczd | $10.5 Bil |